---
title: "Axogen (AXGN) Q1 2025 Earnings Transcript"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284438650.md"
description: "The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc."
datetime: "2026-04-28T19:35:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284438650.md)
  - [en](https://longbridge.com/en/news/284438650.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284438650.md)
---

# Axogen (AXGN) Q1 2025 Earnings Transcript

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

### Related Stocks

- [AXGN.US](https://longbridge.com/en/quote/AXGN.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [Stephens Investment Management Group LLC Acquires New Stake in AxoGen, Inc. $AXGN](https://longbridge.com/en/news/286746770.md)
- [AxoGen Q1 revenue beats analyst estimates](https://longbridge.com/en/news/284371655.md)
- [Axogen (AXGN) Is Up 10.3% After Raising 2026 Revenue Outlook Despite Wider Q1 Loss – Has The Bull Case Changed?](https://longbridge.com/en/news/285033467.md)
- [AxoGen's (AXGN) "Buy" Rating Reaffirmed at Canaccord Genuity Group](https://longbridge.com/en/news/281053250.md)
- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)